Evaluation of Aztreonam Dosing Regimens in Patients With Normal and Impaired Renal Function: A Population Pharmacokinetic Modeling and Monte Carlo Simulation Analysis.

about

Evaluation of Aztreonam Dosing Regimens in Patients With Normal and Impaired Renal Function: A Population Pharmacokinetic Modeling and Monte Carlo Simulation Analysis.

Item

http://www.wikidata.org/entity/Q40573594

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Evaluation of Aztreonam Dosing ...... nte Carlo Simulation Analysis.

@en

type

Item

label

Evaluation of Aztreonam Dosing ...... nte Carlo Simulation Analysis.

@en

prefLabel

Evaluation of Aztreonam Dosing ...... nte Carlo Simulation Analysis.

@en

P1476

Evaluation of Aztreonam Dosing ...... nte Carlo Simulation Analysis.

@en

P2093

Diansong Zhou

http://www.w3.org/2001/XMLSchema#string

Hongmei Xu

http://www.w3.org/2001/XMLSchema#string

Jianguo Li

http://www.w3.org/2001/XMLSchema#string

Nidal Al-Huniti

http://www.w3.org/2001/XMLSchema#string

Wangda Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat

Prediction of creatinine clearance from serum creatinine

Pharmacokinetics of aztreonam in patients with various degrees of renal dysfunction

Perl-speaks-NONMEM (PsN)--a Perl module for NONMEM related programming.

PsN-Toolkit--a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM.

Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria

Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae.

Pharmacokinetics of aztreonam in healthy subjects and patients with cystic fibrosis and evaluation of dose-exposure relationships using monte carlo simulation.

Treatment of infections with ESBL-producing organisms: pharmacokinetic and pharmacodynamic considerations.

Background and rationale for revised clinical and laboratory standards institute interpretive criteria (Breakpoints) for Enterobacteriaceae and Pseudomonas aeruginosa: I. Cephalosporins and Aztreonam.

P304

336-344

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCPH.810

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27530649

http://www.w3.org/2001/XMLSchema#string